If you need more lookups,
subscriptions start at $34 USD/month.
Peter Staehr Location
California, United States
Peter Staehr Work
Chief Medical Officer @ (June 2024 - Present)
Chairman PBSS – San Francisco Bay Area @ Pharmaceutical & BioScience Society (PBSS) (December 2021 - Present)
Chief Medical Officer - Consultant @ (November 2022 - April 2025)
Vice President of Clinical Development and Translational Medicine @ (December 2017 - November 2021)
Senior Director, Head Worldwide Clinical Science @ (March 2012 - November 2017)
Senior Medical Director @ Theravance (May 2011 - February 2012)
Senior Director @ (October 2006 - May 2011)
Director @ (January 2002 - September 2006)
Postdoctoral Research Fellow @ (May 2000 - December 2001)
Fellow @ Mainz University Medical Center, Internal Medicine and Cardiology (February 1992 - April 2000)
Peter Staehr Education
Stanford University School of Medicine
Postdoctoral Research Fellow
2000-2001
Johannes Gutenberg University Mainz
MD (Medical School)
Peter Staehr Skills
Biotechnology
Biotechnology Industry
Cardiology
Clinical Development
Clinical Research
Clinical Study Design
Clinical Trials
Diabetes
Drug Development
Drug Discovery
FDA
GCP
Hematology
IND
Life Sciences
Lifesciences
Medical Devices
Oncology
Pain Management
Pharmaceutical Industry
Therapeutic Areas
Translational Medicine
Data Analysis
Cell Culture
Microsoft Excel
Healthcare
Peter Staehr Summary
Peter Staehr, based in California, United States, is currently a Chief Medical Officer at Respira Therapeutics, Inc.. Peter Staehr brings experience from previous roles at Pharmaceutical & BioScience Society (PBSS), Origenis GmbH, ChemoCentryx and Abbott Vascular Inc.. Peter Staehr holds a 2000 - 2001 Postdoctoral Research Fellow @ Stanford University School of Medicine. With a robust skill set that includes Biotechnology, Biotechnology Industry, Cardiology, Clinical Development, Clinical Research and more. Peter Staehr has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Peter Staehr?
Find contact details for 700 million professionals.